


iBET - Instituto de Biologia Experimental e Tecnológica Email Formats
Biotechnology Research • Oeiras, Lisbon, Portugal • 201-500 Employees
iBET - Instituto de Biologia Experimental e Tecnológica Email Formats
iBET - Instituto de Biologia Experimental e Tecnológica uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@ibet.pt), used 79.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@ibet.pt | 79.8% |
{2char} | {2char}@ibet.pt | 11.6% |
{first initial}.{last name} | j.doe@ibet.pt | 4.7% |
{first initial}{last name} | jdoe@ibet.pt | 1.6% |
Key Contacts at iBET - Instituto de Biologia Experimental e Tecnológica
Vanda Guerreiro
Personal Assistant To The Board Of Directors
Ana Luísa Simplicio
Quality Control Director
Estel Rodríguez
Directora De Investigacion
Company overview
| Headquarters | Av. da República, EAN, Oeiras, 2780-157, PT |
| Phone number | +3512780157 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Gene Therapy, Clinical, Nutraceuticals, Production, Manufacturing, Analytical Services, Bioengineering, Biopharmaceuticals, Cell Therapy, Vaccines, Gene Therapy, Viral Vectors, Stem Cells, Proteins, Cdmo, Cell Lines, Bioactives, Bioplastics, Pilot Plant, Virus, Bioprocess Development, New Materials, Cell Based Assays, Atmps, Pre-Clinical Models |
| Founded | 1989 |
| Employees | 201-500 |
| Socials |
About iBET - Instituto de Biologia Experimental e Tecnológica
iBET is a private non-profit research institution specialized in biotechnology research and bioprocess development. iBET acts as an interface between academia and industry while also creating and organizing autonomous knowledge. Our expertise includes the development of bioprocesses for complex biopharmaceuticals and advanced therapies, including vaccines, recombinant proteins, and viral vectors for gene and onco- therapy, stem cells for cell therapy applications; development of in-vitro cell models and protocols for pre-clinical research; analytical tools for quality control of biologics; and structural biology for assisted drug design. Within Food and Health, we develop new solutions for the detection of food frauds, food and water-borne pathogens, and work on the discovery of new bioactive food supplements. To address some environmental issues, we also develop new sustainable, energy saving, processes for both food and water industries. iBET’s infrastructure comprises more than 20 R&D laboratories, a GMP certified Analytical Services Unit, a Mass Spectrometry Unit and a Late-Stage R&D and Bioproduction Unit (2000m2). The new iBET Biofarma building added 29 laboratories to its research and analytical platform infrastructure, including one BLS3 Lab. As an R&D institution, iBET has coordinated over 30 international projects and participated as work-package leader in more than 100 EU-funded projects. iBET has also been involved in some of the most prestigious RD&I and technology transfer projects, with remarkable international impact and has several well established collaborations in Networks of Excellence and with international pharmaceutical companies, such as Bayer, Novartis, Merck, Abbvie, Sanofi, Apceth, AstraZeneca, Glaxo-Smith-Kline , Merck & Co., among others. iBET’s success relies heavily on its large staff of over 250 people, of which about 110 have a PhD degree, and who contribute with advanced skills and experience to our areas of expertise.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
iBET - Instituto de Biologia Experimental e Tecnológica has 98 employees across 10 departments.
Departments
Number of employees
Funding Data
iBET - Instituto de Biologia Experimental e Tecnológica has never raised funding before.
iBET - Instituto de Biologia Experimental e Tecnológica Tech Stack
Discover the technologies and tools that power iBET - Instituto de Biologia Experimental e Tecnológica's digital infrastructure, from frameworks to analytics platforms.
Web servers
Databases
PaaS
Webmail
JavaScript libraries
Programming languages
Security
Miscellaneous
JavaScript frameworks
Blogs
JavaScript libraries
UI frameworks
Frequently asked questions
4.8
40,000 users



